Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Spain Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20052
20061
20074
20081
20092
20104
20115
20123
20133
20147
20154
201611
20177
20185
201910
20208
202111
20225
20234
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated22
Recruiting15
Active, not recruiting14
Unknown status4
Enrolling by invitation2
Not yet recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene16
Novartis Pharmaceuticals15
Janssen Research & Development, LLC7
Bristol-Myers Squibb5
Taiho Oncology, Inc.5
Takeda5
GlaxoSmithKline3
PETHEMA Foundation3
Traws Pharma, Inc.3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes111
Leukemia, Myeloid, Acute42
Leukemia, Myelomonocytic, Chronic21
Anemia13
Leukemia8
Hematologic Neoplasms7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Anemia, Refractory, with Excess of Blasts6
Multiple Myeloma6
Myeloproliferative Disorders5

Trials

Showing 51 to 75 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.